Precision Business Insights has published a report on the global whole genome sequencing market, estimating its value at USD 15.1 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 21.7% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/whole-genome-sequencing-market

Market Definition:

A laboratory technique called whole genome sequencing (WGS) is used to ascertain an organism's genome's whole DNA sequence all at once. It offers a thorough understanding of all genetic data, including both non-coding and coding DNA sections (genes).

Drivers:

1) Declining cost of genome sequencing.
2) Rising demand for personalized and precision medicine.

The global whole genome sequencing market segmentation:

1) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, and Nanopore Sequencing.
2) By Application: Diagnostics, Drug Discovery & Development, and Personalized Medicine.
3) By End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinics.

Regional Overview:
The report also examines the current concerns and their Future Effects on the whole genome sequencing market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the whole genome sequencing market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Illumina, Inc. Thermo Fisher Scientific Inc. Pacific Biosciences of California, Inc. (PacBio) Oxford Nanopore Technologies Ltd. BGI Genomics Co., Ltd. Agilent Technologies, Inc. QIAGEN N.V. Roche Sequencing Solutions (Roche Diagnostics) Beckman Coulter, Inc. (Danaher Corporation) PerkinElmer, Inc. (Revvity) Macrogen Inc. GENEWIZ (Azenta Life Sciences) Novogene Co., Ltd. CD Genomics, MedGenome Labs Ltd. Eurofins Scientific SE, Bionano Genomics, Inc. Dante Labs, Personalis, Inc. Veracyte, Inc. Invitae Corporation, Color Genomics, Helix OpCo LLC, Nebula Genomics, Fulgent Genetics, Inc. 23andMe, Inc. Myriad Genetics, Inc. Ambry Genetics (Konica Minolta) Gene by Gene (FamilyTreeDNA) Centogene N.V.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747